Hormonal steroid contraceptives. I. Physiological and pharmacological considerations.
D000568:Amenorrhea / Q000139:chemically induced; D001940:Breast / Q000187:drug effects; D050260:Carbohydrate Metabolism; D002584:Cervix Uteri / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003276:Contraceptives, Oral / Q000494:pharmacology; D004347:Drug Interactions; D004717:Endometrium / Q000187:drug effects; D004967:Estrogens / Q000378:metabolism / Q000494:pharmacology; D005187:Fallopian Tubes / Q000187:drug effects; D005260:Female; D005298:Fertility / Q000187:drug effects; D005333:Fetus / Q000187:drug effects; D005640:Follicle Stimulating Hormone / Q000096:biosynthesis; D007031:Hypothalamus / Q000187:drug effects; D007774:Lactation / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D007986:Luteinizing Hormone / Q000096:biosynthesis; D008593:Menopause / Q000187:drug effects; D010053:Ovary / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects; D011247:Pregnancy; D011372:Progestins / Q000378:metabolism; D013256:Steroids / Q000502:physiology; D013961:Thyroid Gland / Q000187:drug effects
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D013256:Steroids; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone